Cargando…

A Cost-Effectiveness Analysis Evaluating Endoscopic Surveillance for Gastric Cancer for Populations with Low to Intermediate Risk

BACKGROUND: Gastric cancer (GC) surveillance based on oesophagogastroduodenoscopy (OGD) appears to be a promising strategy for GC prevention. By evaluating the cost-effectiveness of endoscopic surveillance in Singaporean Chinese, this study aimed to inform the implementation of such a program in a p...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Hui Jun, Dan, Yock Young, Naidoo, Nasheen, Li, Shu Chuen, Yeoh, Khay Guan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3873968/
https://www.ncbi.nlm.nih.gov/pubmed/24386314
http://dx.doi.org/10.1371/journal.pone.0083959
_version_ 1782297168531423232
author Zhou, Hui Jun
Dan, Yock Young
Naidoo, Nasheen
Li, Shu Chuen
Yeoh, Khay Guan
author_facet Zhou, Hui Jun
Dan, Yock Young
Naidoo, Nasheen
Li, Shu Chuen
Yeoh, Khay Guan
author_sort Zhou, Hui Jun
collection PubMed
description BACKGROUND: Gastric cancer (GC) surveillance based on oesophagogastroduodenoscopy (OGD) appears to be a promising strategy for GC prevention. By evaluating the cost-effectiveness of endoscopic surveillance in Singaporean Chinese, this study aimed to inform the implementation of such a program in a population with a low to intermediate GC risk. METHODS: Using a reference strategy of no OGD intervention, we evaluated four strategies: 2-yearly OGD surveillance, annual OGD surveillance, 2-yearly OGD screening and 2-yearly screening plus annual surveillance in Singaporean Chinese aged 50-69 years. From a perspective of the healthcare system, Markov models were built to simulate the life experience of the target population. The models projected discounted lifetime costs ($), quality adjusted life year (QALY), and incremental cost-effectiveness ratio (ICER) indicating the cost-effectiveness of each strategy against a Singapore willingness-to-pay of $46,200/QALY. Deterministic and probabilistic sensitivity analyses were used to identify the influential variables and their associated thresholds, and to quantify the influence of parameter uncertainties respectively. RESULTS: With an ICER of $44,098/QALY, the annual OGD surveillance was the optimal strategy while the 2-yearly surveillance was the most cost-effective strategy (ICER  =  $25,949/QALY). The screening-based strategies were either extendedly dominated or cost-ineffective. The cost-effectiveness heterogeneity of the four strategies was observed across age-gender subgroups. Eight influential parameters were identified each with their specific thresholds to define the choice of optimal strategy. Accounting for the model uncertainties, the probability that the annual surveillance is the optimal strategy in Singapore was 44.5%. CONCLUSION: Endoscopic surveillance is potentially cost-effective in the prevention of GC for populations at low to intermediate risk. Regarding program implementation, a detailed analysis of influential factors and their associated thresholds is necessary. Multiple strategies should be considered in order to recommend the right strategy for the right population.
format Online
Article
Text
id pubmed-3873968
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-38739682014-01-02 A Cost-Effectiveness Analysis Evaluating Endoscopic Surveillance for Gastric Cancer for Populations with Low to Intermediate Risk Zhou, Hui Jun Dan, Yock Young Naidoo, Nasheen Li, Shu Chuen Yeoh, Khay Guan PLoS One Research Article BACKGROUND: Gastric cancer (GC) surveillance based on oesophagogastroduodenoscopy (OGD) appears to be a promising strategy for GC prevention. By evaluating the cost-effectiveness of endoscopic surveillance in Singaporean Chinese, this study aimed to inform the implementation of such a program in a population with a low to intermediate GC risk. METHODS: Using a reference strategy of no OGD intervention, we evaluated four strategies: 2-yearly OGD surveillance, annual OGD surveillance, 2-yearly OGD screening and 2-yearly screening plus annual surveillance in Singaporean Chinese aged 50-69 years. From a perspective of the healthcare system, Markov models were built to simulate the life experience of the target population. The models projected discounted lifetime costs ($), quality adjusted life year (QALY), and incremental cost-effectiveness ratio (ICER) indicating the cost-effectiveness of each strategy against a Singapore willingness-to-pay of $46,200/QALY. Deterministic and probabilistic sensitivity analyses were used to identify the influential variables and their associated thresholds, and to quantify the influence of parameter uncertainties respectively. RESULTS: With an ICER of $44,098/QALY, the annual OGD surveillance was the optimal strategy while the 2-yearly surveillance was the most cost-effective strategy (ICER  =  $25,949/QALY). The screening-based strategies were either extendedly dominated or cost-ineffective. The cost-effectiveness heterogeneity of the four strategies was observed across age-gender subgroups. Eight influential parameters were identified each with their specific thresholds to define the choice of optimal strategy. Accounting for the model uncertainties, the probability that the annual surveillance is the optimal strategy in Singapore was 44.5%. CONCLUSION: Endoscopic surveillance is potentially cost-effective in the prevention of GC for populations at low to intermediate risk. Regarding program implementation, a detailed analysis of influential factors and their associated thresholds is necessary. Multiple strategies should be considered in order to recommend the right strategy for the right population. Public Library of Science 2013-12-27 /pmc/articles/PMC3873968/ /pubmed/24386314 http://dx.doi.org/10.1371/journal.pone.0083959 Text en © 2013 Zhou et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Zhou, Hui Jun
Dan, Yock Young
Naidoo, Nasheen
Li, Shu Chuen
Yeoh, Khay Guan
A Cost-Effectiveness Analysis Evaluating Endoscopic Surveillance for Gastric Cancer for Populations with Low to Intermediate Risk
title A Cost-Effectiveness Analysis Evaluating Endoscopic Surveillance for Gastric Cancer for Populations with Low to Intermediate Risk
title_full A Cost-Effectiveness Analysis Evaluating Endoscopic Surveillance for Gastric Cancer for Populations with Low to Intermediate Risk
title_fullStr A Cost-Effectiveness Analysis Evaluating Endoscopic Surveillance for Gastric Cancer for Populations with Low to Intermediate Risk
title_full_unstemmed A Cost-Effectiveness Analysis Evaluating Endoscopic Surveillance for Gastric Cancer for Populations with Low to Intermediate Risk
title_short A Cost-Effectiveness Analysis Evaluating Endoscopic Surveillance for Gastric Cancer for Populations with Low to Intermediate Risk
title_sort cost-effectiveness analysis evaluating endoscopic surveillance for gastric cancer for populations with low to intermediate risk
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3873968/
https://www.ncbi.nlm.nih.gov/pubmed/24386314
http://dx.doi.org/10.1371/journal.pone.0083959
work_keys_str_mv AT zhouhuijun acosteffectivenessanalysisevaluatingendoscopicsurveillanceforgastriccancerforpopulationswithlowtointermediaterisk
AT danyockyoung acosteffectivenessanalysisevaluatingendoscopicsurveillanceforgastriccancerforpopulationswithlowtointermediaterisk
AT naidoonasheen acosteffectivenessanalysisevaluatingendoscopicsurveillanceforgastriccancerforpopulationswithlowtointermediaterisk
AT lishuchuen acosteffectivenessanalysisevaluatingendoscopicsurveillanceforgastriccancerforpopulationswithlowtointermediaterisk
AT yeohkhayguan acosteffectivenessanalysisevaluatingendoscopicsurveillanceforgastriccancerforpopulationswithlowtointermediaterisk
AT zhouhuijun costeffectivenessanalysisevaluatingendoscopicsurveillanceforgastriccancerforpopulationswithlowtointermediaterisk
AT danyockyoung costeffectivenessanalysisevaluatingendoscopicsurveillanceforgastriccancerforpopulationswithlowtointermediaterisk
AT naidoonasheen costeffectivenessanalysisevaluatingendoscopicsurveillanceforgastriccancerforpopulationswithlowtointermediaterisk
AT lishuchuen costeffectivenessanalysisevaluatingendoscopicsurveillanceforgastriccancerforpopulationswithlowtointermediaterisk
AT yeohkhayguan costeffectivenessanalysisevaluatingendoscopicsurveillanceforgastriccancerforpopulationswithlowtointermediaterisk